NASDAQ:YTEN Yield10 Bioscience (YTEN) Stock Price, News & Analysis $1.62 +0.03 (+1.89%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.62▼$1.8150-Day Range$0.80▼$2.3052-Week Range$0.80▼$54.48Volume1,656 shsAverage Volume121,958 shsMarket Capitalization$1.04 millionP/E RatioN/ADividend YieldN/APrice Target$84.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Yield10 Bioscience alerts: Email Address Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About Yield10 Bioscience Stock (NASDAQ:YTEN)Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.Read More YTEN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YTEN Stock News HeadlinesJuly 17, 2024 | globenewswire.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 27, 2024 | Stansberry Research (Ad)Former Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.June 17, 2024 | globenewswire.comRothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in CamelinaMay 23, 2024 | globenewswire.comYield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide LabelMay 22, 2024 | markets.businessinsider.comHold Rating on Yield10 Bioscience Amid Commercialization Challenges and Financial UncertaintiesMay 16, 2024 | investorplace.comYTEN Stock Earnings: Yield10 Bioscience Misses EPS, Misses Revenue for Q1 2024May 15, 2024 | marketwatch.comYield10 Bioscience Shares Plumb New Depths After Nasdaq DelistingJuly 27, 2024 | Stansberry Research (Ad)Former Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.May 15, 2024 | globenewswire.comYield10 Bioscience Announces First Quarter 2024 Financial ResultsMay 15, 2024 | globenewswire.comYield10 Bioscience Announces Delisting from NasdaqMay 1, 2024 | markets.businessinsider.comYield10 Bioscience Sets 1-for-24 Reverse Stock SplitMay 1, 2024 | msn.comYield10 Bioscience to implement reverse stock splitMay 1, 2024 | globenewswire.comYield10 Bioscience Announces 1-for-24 Reverse Stock SplitApril 5, 2024 | finance.yahoo.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call TranscriptApril 3, 2024 | markets.businessinsider.comHold Recommendation on Yield10 Bioscience Amid Commercialization and Capital UncertaintiesApril 2, 2024 | finance.yahoo.comQ4 2023 Yield10 Bioscience Inc Earnings CallApril 1, 2024 | investorplace.comYTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023See More Headlines Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural production - crops Sub-IndustryN/A Current SymbolNASDAQ:YTEN CUSIPN/A CIK1121702 Webwww.yield10bio.com Phone(617) 583-1700Fax617-583-1768Employees29Year Founded1992Price Target and Rating Average Stock Price Target$84.00 High Stock Price Target$96.00 Low Stock Price Target$72.00 Potential Upside/Downside+5,085.2%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($36.4249) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,450,000.00 Net MarginsN/A Pretax Margin-4,381.67% Return on EquityN/A Return on Assets-262.09% Debt Debt-to-Equity RatioN/A Current Ratio0.34 Quick Ratio0.34 Sales & Book Value Annual Sales$60,000.00 Price / Sales17.28 Cash FlowN/A Price / Cash FlowN/A Book Value($4.97) per share Price / Book-0.33Miscellaneous Outstanding Shares640,000Free Float604,000Market Cap$1.04 million OptionableNot Optionable Beta1.36 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Oliver P. Peoples Ph.D. (Age 66)Co-Founder, President, CEO & Director Comp: $358.39kDr. Kristi D. Snell Ph.D. (Age 56)VP of Research & Chief Science Officer Comp: $287.14kMs. Lynne H. Brum (Age 60)VP of Planning & Corporate Communications and Secretary Comp: $287.14kMr. Charles B. Haaser (Age 68)VP of Finance, Chief Accounting Officer & Treasurer Comp: $236.41kKey CompetitorsArcadia BiosciencesNASDAQ:RKDAAfrican AgricultureNASDAQ:AAGREdible GardenNASDAQ:EDBLCortevaNYSE:CTVAFresh Del Monte ProduceNYSE:FDPView All CompetitorsInsidersJack W SchulerSold 1,500 sharesTotal: $7,560.00 ($5.04/share)Jack W SchulerSold 1,458 sharesTotal: $8,398.08 ($5.76/share)Jack W SchulerSold 1,580 sharesTotal: $11,376.00 ($7.20/share)Jack W SchulerSold 1,724 sharesTotal: $12,826.56 ($7.44/share)Jack W SchulerBought 31,875 shares on 8/15/2023Total: $497,250.00 ($15.60/share)View All Insider Transactions YTEN Stock Analysis - Frequently Asked Questions How have YTEN shares performed this year? Yield10 Bioscience's stock was trading at $5.7432 at the start of the year. Since then, YTEN stock has decreased by 71.8% and is now trading at $1.62. View the best growth stocks for 2024 here. How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its quarterly earnings data on Wednesday, May, 15th. The specialty chemicals company reported ($4.77) earnings per share for the quarter. The specialty chemicals company earned $0.30 million during the quarter. When did Yield10 Bioscience's stock split? Yield10 Bioscience's stock reverse split before market open on Friday, May 3rd 2024. The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Yield10 Bioscience? Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Yield10 Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD) and Viking Therapeutics (VKTX). This page (NASDAQ:YTEN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Yield10 Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
